The right diet can boost potency of cancer drugs

Another challenge will be determining which patients are most likely to benefit from the dietary changes, says cancer researcher Chi Van Dang of the Ludwig Institute for Cancer Research in New York City. Some pharmaceutical companies have moved away from targeting cancer metabolism, in part because of the difficulty in deciding which patients to target.

“Individual metabolism is quite variable,” says Dang, and people likely won’t respond to these treatments in the same way.

Sign up for the daily Nature Briefing email newsletter

Stay up to date with what matters in science and why, handpicked from Nature and other publications worldwide.

Sign Up